Dechra Pharmaceuticals, founded in 1997 following a management buy-out from Lloyds Chemists, develops prescription only veterinary medicines for dogs, cats and horses. Most of its projects involve adapting treatments, currently used by humans, for the animal market. Expertise is in the development, manufacturing and sales and marketing of high quality products exclusively for veterinarians worldwide. It listed in London in 2000.
CEO: |
Ian Page |
CFO: |
Paul Sandland |
Non-Executive Director: |
Geeta Gopalan, John Shipsey |
Non-Executive Chairman: |
Alison Platt |
Senior Independent Director: |
Lawson Macartney |
Independent Non-Executive Director: |
Lisa Bright |
Address: |
24 Cheshire Avenue, Cheshire Business Park, Lostock Gralam, Northwich, United Kingdom |
Phone: |
+44 (0) 160 681 4730 |
Fax: |
+44 (0) 160 681 4731 |
Website: |
http://www.dechra.com/ |
Email: |
|